Bridgewater Associates’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,277
Closed -$1.83M 848
2022
Q3
$1.83M Sell
75,277
-1,529
-2% -$52.6K 0.01% 583
2022
Q2
$2.38M Buy
76,806
+6,844
+10% +$182K 0.01% 642
2022
Q1
$2.44M Buy
69,962
+20,256
+41% +$766K 0.01% 630
2021
Q4
$2.94M Buy
49,706
+6,591
+15% +$456K 0.02% 409
2021
Q3
$2.87M Sell
43,115
-3,668
-8% -$226K 0.02% 376
2021
Q2
$2.95M Buy
+46,783
New +$2.63M 0.02% 426

Other funds holding CYRX

Bridgewater Associates's CYRX Position: Q4 2022 in Review

Bridgewater Associates sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 75,277 shares — an estimated $1.83M sold.

Bridgewater Associates first reported a position in CYRX in Q2 2021 and held it in 6 quarters. The position peaked at $2.95M in Q2 2021. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.

  • Bridgewater Associates reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
  • Bridgewater Associates sold 75,277 CryoPort shares in Q4 2022, an estimated $1.83M.
  • Bridgewater Associates first reported a position in CryoPort in Q2 2021 and held it in 6 quarters.
  • Bridgewater Associates's CryoPort position peaked at $2.95M in Q2 2021.
  • 171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.

Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.